Climb Biotherapeutics, Inc. (CLYM)
Market Open
15 Jun, 14:41
NASDAQ (NMS) NASDAQ (NMS) Primary $
11. 48
+0.04
+0.3497%
$
780.03M Market Cap
- P/E Ratio
- Div Yield
122,112 Volume
0 Eps
$ 11.44
Previous Close 
Want to track CLYM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Climb Biotherapeutics, Inc. (CLYM) Statistics
Valuation metrics
Market Cap 780.03M
Enterprise value 772.15M
Trailing P/E (ttm) -14.78
Forward P/E -
PEG ratio -0.33
Price/Sales (ttm) -
Price/Book (mrq) 5.27
Enterprise Value/Revenue -
Enterprise Value/EBITDA -13.81
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 858.85K
Average volume (90 days) 741K
Price summary
52-Week low 1.16
52-Week high 12.48
Beta -
50-Day moving average 10.58
200-Day moving average 6.5
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.35%
Return on equity -0.31%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.77
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 1.61
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 27.86%
Book value per share (mrq) 2.17
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
